04/06/2024  21:23:58 Diferencia -0.40 Volumen Bid21:23:58 Ask21:23:58 Capitalización de mecado Dividendo A. P/E Ratio
55.02EUR -0.72% -
Volumen de negocios: -
55.02Volumen de oferta: - 56.04Tamaño/ Volumen/ Formato de Ask: - 10.72 mil millonesEUR 0.90% 18.77

Descripción de negocio

Eurofins Scientific is a leading international group of laboratories providing a unique range of analytical testing services to the pharmaceutical, food, environmental and consumer products industries and to governments. Eurofins believes it is a worldwide leader in its field. The Group offers a portfolio of more than 150,000 validated analytical methods for evaluating the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products. Through research and development and acquisitions, the Group draws on the latest developments in the field of biotechnology and analytical chemistry to offer its clients unique analytical solutions and the most comprehensive range of testing methods.
 

Consejo de gestión & Consejo de supervisión

CEO
Dr. Gilles G. Martin
Consejo de gestión
Gabriel Julia, Dr. Timothy S. Oostdyk, Joachim Reichelt, Yvoine Rémy, François Vigneau, Brian Williams, Laurent Lebras, Dr. Christian Wurst, Sean Murray, Ramón Armas, Beth DiPaolo, Natalia Shuman, Gregg Tiemann
Consejo de supervisión
Dr. Gilles Martin, Dr. Yves-Loïc Martin, Evie Roos, Fereshteh Pouchantchi, Ivo Rauh, Pascal Rakovsky, Patrizia Luchetta, Valérie Hanote
 

Datos de la empresa

Nombre: Eurofins Scientific S.A.
Dirección: Chausée de Malines 455,B-1950 Kraainem
Teléfono: +32-2-766-1620
Fax: +32-2-766-1639
E-mail: info@eurofins.com
Internet: www.eurofins.com
Industria: Biotechnology
Sector: Biotechnology
Subsector: Biotechnology
Fin del año financiero: 31/12
Acciones de libre circulación: 66.60%
Fecha de OPI: 24/10/1997

Relación con inversores

Nombre: -
IR teléfono: +32-2-769-7383
IR-fax: -
IR e-mail: ir@eurofins.com

Calendario de la empresa

CW 27 | 03/07/2024 Ex-Dividend
CW 27 | 04/07/2024 Record Date
CW 27 | 05/07/2024 Dividend Payment
CW 30 | 24/07/2024 Interim Report 2nd Quarter/6 Months
CW 43 | 22/10/2024 Interim Report 3rd Quarter/9 Months
 

Accionistas mayoritarios

Free Floa
 
66.80%
Martin Family
 
32.70%
Treasury shares
 
0.50%